BiotechTube
Home/Taysha Gene Therapies/Sean P. Nolan
SP

Sean P. Nolan

Chief Executive Officer and Board Chairman

Taysha Gene Therapies

Therapeutic Areas

NeurologyRare Diseases

Taysha Gene Therapies Pipeline

DrugIndicationPhase
TSHA-102Rett SyndromePhase 1/2
TSHA-120Giant Axonal Neuropathy (GAN)Phase 1/2
TSHA-104SURF1-Associated Leigh SyndromePreclinical
TSHA-103SLC6A1 HaploinsufficiencyPreclinical